XBP vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

XBP

53.5
AI Score
VS
XBP Wins

NIVF

45.6
AI Score

Investment Advisor Scores

XBP

54score
Recommendation
HOLD

NIVF

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XBP NIVF Winner
Revenue 872.69M 4.73M XBP
Net Income -215.15M 9.88M NIVF
Gross Margin 21.6% 20.2% XBP
Net Margin -24.7% 209.0% NIVF
Operating Income -105.44M -10.73M NIVF
ROE 14.8% 37.1% NIVF
ROA -55.1% 30.2% NIVF
Total Assets 390.42M 32.72M XBP
Cash 11.63M 758,621 XBP
Current Ratio 0.07 3.12 NIVF
Free Cash Flow 16.97M -11.06M XBP

Relative Price Performance (Last 90 Days)

XBP 1M: +22.3% · 3M: +0.3% NIVF 1M: +41.7% · 3M: -61.8%

Current Technical Phase

XBP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 52

RSI (14): 52.1 · Price: $2.91

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.3 · Price: $0.65

Fundamentals Snapshot

Metric XBP NIVF
Market Cap
Forward P/E -1.9 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin -0.1% -3.5%
EPS -3.50 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XBP is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.